Literature DB >> 22868973

Human enhancement drugs and the pursuit of perfection.

Jim McVeigh1, Michael Evans-Brown, Mark A Bellis.   

Abstract

The emerging threat to public health posed by the use of human enhancement drugs has remained largely unrecognised. In attempts to become stronger, happier or smarter, or to look thinner, younger or more beautiful, people are turning to a diverse range of pharmaceuticals. The widespread availability of drugs with the potential to improve human attributes, appearance and abilities has generated a new and growing audience of users. Unlike users of drugs such as heroin, cocaine etc, users of human enhancement drugs do not necessarily perceive themselves as 'drug users'. Those attracted to these drugs may have little or no knowledge or understanding of the physical or psychological harm associated with these substances or their potential for addiction. In addition to the potent effects of many human enhancement drugs, there are considerable risks associated to the clandestine nature of the market. The growing number of untested, banned or adulterated drugs and the lack of safeguards and quality assurance in the illicit manufacturing process has resulted in serious harms and fatalities. The ease with which pharmaceuticals can be manufactured and distributed, combined with the significant profits that can be made from the illicit market, has resulted in a growing challenge for policy makers and health systems in many countries. This editorial aims to raise awareness of this emerging drugs situation and provide a brief overview of some of the drugs and their associated risks.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22868973

Source DB:  PubMed          Journal:  Adicciones        ISSN: 0214-4840            Impact factor:   2.979


  9 in total

1.  Availability and quality of illegitimate somatropin products obtained from the Internet.

Authors:  Róbert György Vida; András Fittler; Ivett Mikulka; Eszter Ábrahám; Viktor Sándor; Ferenc Kilár; Lajos Botz
Journal:  Int J Clin Pharm       Date:  2016-11-25

2.  Injection site infections and injuries in men who inject image- and performance-enhancing drugs: prevalence, risks factors, and healthcare seeking.

Authors:  V D Hope; J McVeigh; A Marongiu; M Evans-Brown; J Smith; A Kimergård; J V Parry; F Ncube
Journal:  Epidemiol Infect       Date:  2014-04-08       Impact factor: 4.434

3.  Variability and dilemmas in harm reduction for anabolic steroid users in the UK: a multi-area interview study.

Authors:  Andreas Kimergård; Jim McVeigh
Journal:  Harm Reduct J       Date:  2014-07-02

Review 4.  Facing Counterfeit Medications in Sexual Medicine. A Systematic Scoping Review on Social Strategies and Technological Solutions.

Authors:  Andrea Sansone; Béatrice Cuzin; Emmanuele A Jannini
Journal:  Sex Med       Date:  2021-10-04       Impact factor: 2.491

Review 5.  Adverse Psychiatric Effects Associated with Herbal Weight-Loss Products.

Authors:  F Saverio Bersani; Marialuce Coviello; Claudio Imperatori; Marta Francesconi; Christina M Hough; Giuseppe Valeriani; Gianfranco De Stefano; Flaminia Bolzan Mariotti Posocco; Rita Santacroce; Amedeo Minichino; Ornella Corazza
Journal:  Biomed Res Int       Date:  2015-09-17       Impact factor: 3.411

6.  Prevalence of, and risk factors for, HIV, hepatitis B and C infections among men who inject image and performance enhancing drugs: a cross-sectional study.

Authors:  Vivian D Hope; Jim McVeigh; Andrea Marongiu; Michael Evans-Brown; Josie Smith; Andreas Kimergård; Sara Croxford; Caryl M Beynon; John V Parry; Mark A Bellis; Fortune Ncube
Journal:  BMJ Open       Date:  2013-09-12       Impact factor: 2.692

7.  Risk of HIV and Hepatitis B and C Over Time Among Men Who Inject Image and Performance Enhancing Drugs in England and Wales: Results From Cross-Sectional Prevalence Surveys, 1992-2013.

Authors:  Vivian D Hope; Ross Harris; Jim McVeigh; Katelyn J Cullen; Josie Smith; John V Parry; Daniela DeAngelis; Fortune Ncube
Journal:  J Acquir Immune Defic Syndr       Date:  2016-03-01       Impact factor: 3.731

Review 8.  Abuse of Prescription Drugs in the Context of Novel Psychoactive Substances (NPS): A Systematic Review.

Authors:  Fabrizio Schifano; Stefania Chiappini; John M Corkery; Amira Guirguis
Journal:  Brain Sci       Date:  2018-04-22

Review 9.  Treatments for people who use anabolic androgenic steroids: a scoping review.

Authors:  Geoff Bates; Marie-Claire Van Hout; Joseph Tay Wee Teck; Jim McVeigh
Journal:  Harm Reduct J       Date:  2019-12-30
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.